Why Ozempic isn’t just getting celebrities thin: it’s killing the diet industry too

  • 📰 nypost
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 67%

Business News News

Business Business Latest News,Business Business Headlines

Weight loss drugs are having a dramatic impact on more than the waistlines of celebrities like Sharon Osborne and Dolores Catania. Weightwatchers and others are moving into diet drugs to survive.

Which is good news for longtime dieters, but not so much for companies whose sole mission is selling weight-loss plans and prepared meals to millions of overweight Americans.

In April, WW purchased Sequence, a telehealth subscription service that connects patients with doctors who can prescribe obesity and diabetes drugs. “You need to read between the lines to find it, but it’s there: A tacit admission that the plans they were pushing didn’t actually work – at least, not long term, for the vast majority of clients. WW and JC were peddling low-cal snake oil.

“The issue is that it still sends a message that joining a weight loss program is the answer; we must reframe overall health as the main goal. There is much more to health than just weight.” WW, the new name for Weight Watchers, has recently seen a tiny uptick after moving into diet drugs but its value has collapsed as dieting changes radically.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 91. in BUSİNESS

Business Business Latest News, Business Business Headlines